Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients

被引:0
作者
Min Deng
Shao-Hua Li
Xu Fu
Xiao-Peng Yan
Jun Chen
Yu-Dong Qiu
Rong-Ping Guo
机构
[1] Sun Yat-Sen University Cancer Center,Department of Liver Surgery
[2] State Key Laboratory of Oncology in South China,Department of Hepatopancreatobiliary Surgery, Nanjing Drum Tower Hospital
[3] Collaborative Innovation Center for Cancer Medicine,Department of Pathology, Nanjing Drum Tower Hospital
[4] The Affiliated Hospital of Nanjing University Medical School,undefined
[5] The Affiliated Hospital of Nanjing University Medical School,undefined
来源
Cancer Cell International | / 21卷
关键词
Intrahepatic; Cholangiocarcinoma; Programmed death-ligand 1; CD8+ T cell; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 197 条
[1]  
Valle JW(2021)Biliary tract cancer Lancet 397 428-444
[2]  
Kelley RK(2014)Cholangiocarcinoma Lancet 383 2168-2179
[3]  
Nervi B(2014)Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma J Hepatol 60 1268-1289
[4]  
Oh DY(2007)Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution Ann Surg 245 755-762
[5]  
Zhu AX(2015)Epidemiology of cholangiocarcinoma Best Pract Res Clin Gastroenterol 29 221-232
[6]  
Razumilava N(2012)Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes Hepatology 55 1876-1888
[7]  
Gores GJ(2011)Risk factors for cholangiocarcinoma Hepatology 54 173-184
[8]  
Bridgewater J(2015)Hepatolithiasis and intrahepatic cholangiocarcinoma: a review World J Gastroenterol 21 13418-13431
[9]  
Galle PR(2015)Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies World J Surg Oncol 13 161-754
[10]  
Khan SA(2014)The diagnosis and treatment of cholangiocarcinoma Dtsch Arztebl Int 111 748-2900